(Q53583365)

15 May 2018

title

Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer. (English)

1 reference

15 May 2018

1 reference

Ruixue Huang

1

1 reference

15 May 2018

Dequn Huang

series ordinal

2

1 reference

15 May 2018

Weirong Dai

series ordinal

3

1 reference

15 May 2018

Fei Yang

series ordinal

4

1 reference

15 May 2018

publication date

13 March 2015

1 reference

15 May 2018

Molecular and Cellular Biochemistry

published in

1 reference

15 May 2018

volume

404

1 reference

15 May 2018

issue

1-2

1 reference

15 May 2018

page(s)

251-257

1 reference

15 May 2018

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

The global breast cancer burden: variations in epidemiology and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Cadherins and catenins in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Signalling to chromatin through post-translational modifications of HMGN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Increased expression of high mobility group A proteins in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

Expression of HMGA1 and ezrin in laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2384-4

The HMGA proteins: a myriad of functions (Review).

21 January 2018

1 reference

12 December 2020

Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization

1 reference

12 December 2020

Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins

1 reference

12 December 2020

Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer

1 reference

12 December 2020

Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas

1 reference

12 December 2020

HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.

1 reference

12 December 2020

High mobility group A1 and cancer: potential biomarker and therapeutic target

1 reference

12 December 2020

Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis

1 reference

12 December 2020

Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins

1 reference

12 December 2020

10.1007/S11010-015-2384-4

Identifiers

DOI

1 reference

15 May 2018

release_zbmba7egejelzhnbs3p3tdm56e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zbmba7egejelzhnbs3p3tdm56e

24 November 2022

mapped directly with Wikidata item

1 reference

15 May 2018